Edition:
India

Insider Trading: Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

18.70USD
19 Sep 2019
Change (% chg)

$-0.00 (-0.03%)
Prev Close
$18.71
Open
$18.75
Day's High
$18.75
Day's Low
$18.70
Volume
117,257
Avg. Vol
368,619
52-wk High
$18.90
52-wk Low
$8.39

All Insider Trades
Trading Date Name Title Type Shares Traded Price
25 Apr 2019

Hassler Randal

Officer Sell 1,738 $13.85
25 Apr 2019

Bucher (James B)

General Counsel Sell 1,897 $13.85
25 Apr 2019

Smith (Jeffrey T L)

Officer Sell 4,847 $13.73
25 Apr 2019

Benedict (Larry K)

Officer Sell 1,734 $13.65
25 Apr 2019

Lavelle (Erin M)

Chief Operating Officer Sell 1,434 $13.67
23 Apr 2019

Bucher (James B)

General Counsel Buy 7,810 $0.00
23 Apr 2019

Hassler Randal

Officer Buy 7,172 $0.00
23 Apr 2019

Smith (Jeffrey T L)

Officer Buy 9,288 $0.00
23 Apr 2019

Benedict (Larry K)

Officer Buy 7,055 $0.00
23 Apr 2019

Lavelle (Erin M)

Chief Operating Officer Buy 5,842 $0.00
4 Mar 2019

Redmile Group, L.L.C.

Unknown Buy 1,739,130 $11.50
3 Dec 2018

Smith (Jeffrey T L)

Officer Sell 5,044 $13.84
3 Dec 2018

Smith (Jeffrey T L)

Officer Buy 5,044 $0.99
30 Nov 2018

Bucher (James B)

General Counsel Buy 273 $9.35
30 Nov 2018

Latham (John A)

Officer Buy 487 $9.35
30 Nov 2018

Benedict (Larry K)

Officer Buy 954 $9.35
1 Nov 2018

Latham (John A)

Officer Buy 18,181 $10.00
1 Nov 2018

Smith (Jeffrey T L)

Officer Buy 5,040 $0.99
1 Nov 2018

Latham (John A)

Officer Sell 1,319 $13.78
1 Nov 2018

Latham (John A)

Officer Sell 23,683 $13.40
1 Nov 2018

Latham (John A)

Officer Buy 6,821 $6.77
1 Nov 2018

Smith (Jeffrey T L)

Officer Sell 5,040 $13.42
1 Oct 2018

Smith (Jeffrey T L)

Officer Sell 3,040 $15.26
1 Oct 2018

Smith (Jeffrey T L)

Officer Buy 5,040 $0.99
1 Oct 2018

Latham (John A)

Officer Sell 6,554 $15.97

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 191
Total Shares Held: 91,778,289
3 Mo. Net Change: 322,100
# New Positions: 8
# Closed Positions: 4
# Increased Positions: 13
# Reduced Positions: 14
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

Robert Azelby

51 2018 President, Chief Executive Officer, Director

Carlos Campoy

54 2018 Chief Financial Officer

Erin Lavelle

41 2018 Chief Operating Officer

James Bucher

53 2019 Executive Vice President, General Counsel

Randal Hassler

61 2018 Executive Vice President, Pharmaceutical Operations

Nadia Dac

49 2019 Chief Commercial Officer

Jeffrey Smith

59 2017 Managing Director of Alder BioPharmaceuticals Limited

Paul Streck

56 2019 Chief Medical Officer

Paul Cleveland

62 2018 Director

Paul Carter

58 2015 Independent Director

Jeremy Green

45 2018 Independent Director

A. Bruce Montgomery

65 2010 Independent Director

Heather Preston

53 2007 Independent Director

Clay Siegall

58 2005 Independent Director

Wendy Yarno

64 2017 Independent Director